Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R,5aR,8aR,9R),5aβ,8aα,9β(R*)]]-

Englisch Name:: Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-

Synonyma:: Etoposide EP impurity R (S configuration);Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(...;Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 8

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R,5aR,8aR,9R),5aβ,8aα,9β(R*)]]- Eigenschaften

Global( 8)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Guangzhou CATO Research Chemicals Inc.	+86-020-81960175-617 +8615602392859	Intermediate@cato-chem.com	China	8322	58
Moxin Chemicals	+8617320513646	mike@molcoo.com	China	9532	58
TOSUN PHARM	020-61855200 13326451905	260366801@qq.com	China	7812	58
Hubei Xinyang Medical Technology Co., Ltd	15347293736 15347293736	2853117764@qq.com	China	8871	58
Henan Vcommend Consultrading Co., Ltd.	13393721940; 13393721940	sales@vcommend.com	China	10005	58
ShenZhen H&D Pharmaceutical Technology Co., LTD	13217415044	wangshuai@hdimpurity.com	China	7854	58
Cato Research Chemicals Inc.	13342851930	3008394369@qq.com	China	15726	58
Chengdu Peter-like Biotechnology Co., Ltd.	028-81700200 13308200041	2851167782@qq.com	China	11183	58

Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(R*)]]-
Etoposide EP impurity R (S configuration)
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-glucopyranosyl)oxy]-5-[4-[[5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]-3,5-dimethoxyphenyl]-5,8,8a,8-tetrahydro-, [5R-[5α(5R*,5aR*,8aR*,9R*),5aβ,8aα,9β(...
149839-65-6